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Introduction:
Online continuous glucose monitoring during sport practise would be highly valuable to
insulin-treated diabetic patients. We assessed whether this goal could be reached by using
a subcutaneous'needle-type' enzymatic sensor'
Material and methods:
10 patients (5F/5M), aged 51 t L7, with type 1 diabetes since 24 * LL years, treated by
continuous subcutaneous insulin infusion (CSII) for more than 1 year (HbA r,: 7'5 t 0'B
ola), pertormed a 3Omin-exercise bout at constant, high intensity load (15o/o above their
inéividual ventilatory threshold), on a cycle ergometer, as a routine clinical care evaluation
to state their ability to practise competitive sport. All patients wore a subcutaneous "needle
type" enzymatic glucose sensor linked to a portable monitor (Guardian RT@, Medtronic-
MiniMed, Northridge, CA, USA) which was settled on the previous eve, Sensor calibration
was peformed against capillary blood glucose immediately before exercise. Blood glucose
values according to the sensor were recorded every 5 minutes frorn T-10 to T+30, and
then every 10 minutes during recovery period from T+ 30 to T+90. These recorded values
were compared to blood glucose assays performed on sirnultaneously collected peripheral
venous samples.
Results:
Sensor functioning and tolerance raised no problem but in one sensor whose adequate
calibration could not be obtained. An average blood glucose decrease of 113 * 63 mg/dl
occurred during exercise bouts, while sensor glucose decreased by BB *.49 mgldl. t46
paired glucose values could be analyzed. The correlation factor between sensor and blood
glucose values was 0.957 with an intercept of 0.275. Mean difference between paired
values according to Bland-Altman analysis was 22 mg/dl. Clarke error grid showed BB%
of paired pointJ in A and B zones, while 4, 8 and Oo/o of paired points were in C, D and
E zbnes, respectively. All paired points in C zone could be attributed to the single sensor
whose calibration failed.
Conclusions:
Blood glucose decrease during intensive exercise bouts performed by CSll-treated diabetic
patients can be estimated with acceptable clinical accuracy by online monitoring using a
subcutaneous sensor. Whether sensor accuracy can maintain has to be assessed by trials
includlng a prolonged effort, while reliability of hypo-alarms, non assessable in the present
trial, will also require further studies.
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